Neuro-Oncology
Reviews


Volume 16 Number 1
January 2014


Home > Publications > Neuro-Oncology Reviews > Volume 16, Year 2014 > Number 1, January



Contents


Central nervous system tumors


Gliomas


High-grade gliomas


Low-grade gliomas


Diffuse astrocytic and oligodendroglial tumors


Glioblastoma


Ependymal tumors


Ependymoma


Embryonal tumors


Medulloblastoma


Metastatic tumors



Central nervous system tumors


Liu Y, Lu Y, Wang J, Xie L, Li T, He Y, Peng Q, Qin X, Li S.
Association between non-steroidal anti-inflammatory drug use and brain tumour risk: a meta-analysis.
Br J Clin Pharmacol. 2013 Dec 17. 2014;78(1):58-68. doi: 10.1111/bcp.12311
. PMID: 24341448. Meta-analysis.




Perucca E.
Optimizing antiepileptic drug treatment in tumoral epilepsy.
Epilepsia. 2013 Dec 12. 2013;54 Suppl 9:97-104. doi: 10.1111/epi.12452
. PMID: 24328881. Review.



Gliomas


Zhao H, Cai W, Su S, Zhi D, Lu J, Liu S.
Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects.
Tumour Biol. 2013 Dec 18. 2014;35(4):3875-80. doi:10.1007/s13277-013-1514-4
. PMID: 24347487. Meta-analysis.




Zhao J, Ma W, Zhao H.
Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.
Neuro Oncol. 2013 Dec 4. 2014;16(1):103-12. doi: 10.1093/neuonc/not145
. PMID: 24311641. Meta-analysis.



High-grade gliomas



Hofer S, Rushing E, Preusser M, Marosi C.
Molecular biology of high-grade gliomas: what should the clinician know?
Chin J Cancer. 2013 Dec 11. 2014;33(1):4-7. doi: 10.5732/cjc.013.10218
. PMID: 24325789. Review.



Low-grade gliomas



Huse JT, Wallace M, Aldape KD, Berger MS, Bettegowda C, Brat DJ, Cahill DP, Cloughesy T, Haas-Kogan DA, Marra M, Miller CR, Nelson SJ, Salama SR, Soffietti R, Wen PY, Yip S, Yen K, Costello JF, Chang S.
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.
Neuro Oncol. 2013 Dec 4. 2014;16(2):173-8. doi: 10.1093/neuonc/not229
. PMID: 24305708. Meeting report.



Diffuse astrocytic and oligodendroglial tumors



Glioblastoma


°

Arrillaga-Romany I, Reardon DA, Wen PY.
Current status of antiangiogenic therapies for glioblastomas.
Expert Opin Investig Drugs. 2013 Dec 10. 2014;23(2):199-210. doi: 10.1517/13543784.2014.856880
. PMID: 24320142. Review.




Butowski N, Wong ET, Mehta MP, Wilson LK.
A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.
Semin Oncol. 2013 Oct 10. 2013;40(6):S2-4. doi: 10.1053/j.seminoncol.2013.10.002
. PMID: 24331200. Meeting report;




Han K, Ren M, Wick W, Abrey L, Das A, Jin J, Reardon DA.
Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials.
Neuro Oncol. 2013 Dec 12. 2014;16(5):696-706. doi: 10.1093/neuonc/not236
. PMID: 24335699. Meta-analysis.




Hernández-Pedro NY, Rangel-López E, Vargas Félix G, Pineda B, Sotelo J.
An update in the use of antibodies to treat glioblastoma multiforme.
Autoimmune Dis. 2013 Nov 5. 2013;2013:716813. doi: 10.1155/2013/716813
. PMID: 24294521. Review.



Ependymal tumors



Ependymoma



Liu Z, Li J, Liu Z, Wang Q, Famer P, Mehta A, Chalif D, Wang Y, Li JY.
Supratentorial cortical ependymoma: Case series and review of the literature.
Neuropathology. 2013 Dec 20. 2014;34(3):243-52. doi: 10.1111/neup.12087
. PMID: 24354554. Case series & Review.



Embryonal tumors



Medulloblastoma



MacDonald TJ, Aguilera D, Castellino RC.
The rationale for targeted therapies in medulloblastoma.
Neuro Oncol. 2013 Dec 4. 2014;16(1):9-20. doi: 10.1093/neuonc/not147
. PMID: 24305711. Review.




Morgan AA, Achrol AS, Li MD, Khatri PJ, Cheshier SH.
Multiplex meta-analysis of medulloblastoma expression studies with external controls.
Pac Symp Biocomput. 2014:99-109. doi:
10.1142/9789814583220_0010. PMID: 24297537. Meta-analysis.



Metastatic tumors


Gállego Pérez-Larraya J, Hildebrand J.
Brain metastases.
Handb Clin Neurol. 2013 Dec 21. 2014;121:1143-57. doi: 10.1016/B978-0-7020-4088-7.00077-8
. PMID: 24365409. Review.



bottom